Glaucoma Diagnostic Devices Market: By Product Type Imaging Systems, Retinal Tomography and Angiography Systems, Spectral Domain Optical Coherence Tomography Systems, Tonometers, Visual Field Testing Equipment, Others), By Disease Type, By End Users and Region Forecast 2019-2030
Glaucoma Diagnostic Devices Market size was valued at US$ 360 million in 2023 and is expected to reach US$ 2243 million by 2030, at a CAGR of 28.3% from 2024-2030. Glaucoma is a disease characterized by an increase in the intraocular pressure in the eye that leads to optic nerve damage and causes loss of vision or blindness. The most common types of glaucoma include closed-angle glaucoma and open-angle glaucoma. Glaucoma can be diagnosed by determining the status of the optic nerve, intraocular pressure, and drainage angle. An increase in the geriatric population, escalation in the prevalence rate of glaucoma disease, technological advancements in glaucoma diagnostic devices, and sophisticated healthcare infrastructure in developed countries are expected to fuel the market. However, stringent regulatory guidelines for product approval, high cost of devices, and lack of well-trained professionals in underdeveloped countries may restrain the growth of the market.
Study Period
2025-2031Base Year
2024CAGR
28.3%Largest Market
Asia-PacificFastest Growing Market
North-America
Drivers: High prevalence of glaucoma & rise in geriatric population worldwide. Restraints: Less awareness regarding glaucoma and available surgery devices in underdeveloped economies.
North America glaucoma diagnostic devices market expected to grow at a significant rate due increase in the prevalence of glaucoma (As per, Glaucoma Research Foundation survey, approximately 1 out of 10,000 newborn babies are born with glaucoma disease in U.S.), increase in healthcare expenditure, and rise in awareness about the glaucoma disease. The European market is expected to present lucrative growth due to the adoption of newer diagnostic devices, the rise in prevalence of glaucoma in Italy, Germany, Spain, and Austria, and the presence of a huge number of companies for diagnostic devices in the region. The Asia Pacific is poised to grow at a notable rate due to development in healthcare infrastructure, large patient pool in China, India, and Japan. Latin America is poised to grow at a significant rate due to advances in healthcare infrastructure in emerging countries such as Brazil, expansion of businesses by the market players, and adoption of newer devices. The Middle East and Africa growth attributed to rise in prevalence of glaucoma in Africa region and rise in awareness about the glaucoma diagnosis.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2023 |
US$ 360 million |
|
Market Size in 2030 |
US$ 2243 million |
|
Market CAGR |
28.3% |
|
By Product Type |
|
|
By Disease Type |
|
|
By End user |
|
|
By Region |
|
Download Free Sample Report
The global glaucoma diagnostic devices market size was valued at US$ 360 million in 2023 and is projected to grow at a CAGR of 28.3% by 2030.
The market key players are: Carl Zeiss Meditec AG (Germany) Topcon Corporation (Japan) Heidelberg Engineering GmbH (Germany) NIDEK CO., LTD (Japan) Optovue, Incorporated (U.S.) Leica Microsystems (Germany) HAAG-STREIT GROUP (U.S.)
The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1. Executive Summary |
| 2. Global Glaucoma Diagnostic Devices Market Introduction |
| 2.1.Global Glaucoma Diagnostic Devices Market - Taxonomy |
| 2.2.Global Glaucoma Diagnostic Devices Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Disease Type |
| 2.2.3.End Users |
| 2.2.4.Region |
| 3. Global Glaucoma Diagnostic Devices Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Glaucoma Diagnostic Devices Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Glaucoma Diagnostic Devices Market By Product Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Corneal Pachymeters |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Optical Coherence Tomography (OCT) Imaging Systems |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Retinal Tomography and Angiography Systems |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Tonometers |
| 5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Visual Field Testing Equipment |
| 5.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Others |
| 5.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 6. Global Glaucoma Diagnostic Devices Market By Disease Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Closed-angle glaucoma |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Open-angle glaucoma |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Pigmentary glaucoma |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Low tension glaucoma |
| 6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Glaucoma Diagnostic Devices Market By End Users, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Ophthalmology Diagnostic Centers |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Research Institutes |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8. Global Glaucoma Diagnostic Devices Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. North America Glaucoma Diagnostic Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. Product Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Corneal Pachymeters |
| 9.1.2.Optical Coherence Tomography (OCT) Imaging Systems |
| 9.1.3.Retinal Tomography and Angiography Systems |
| 9.1.4.Tonometers |
| 9.1.5.Visual Field Testing Equipment |
| 9.1.6.Others |
| 9.2. Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Closed-angle glaucoma |
| 9.2.2.Open-angle glaucoma |
| 9.2.3.Pigmentary glaucoma |
| 9.2.4.Low tension glaucoma |
| 9.2.5.Others |
| 9.3. End Users Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Ophthalmology Diagnostic Centers |
| 9.3.3.Research Institutes |
| 9.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10. Europe Glaucoma Diagnostic Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Corneal Pachymeters |
| 10.1.2.Optical Coherence Tomography (OCT) Imaging Systems |
| 10.1.3.Retinal Tomography and Angiography Systems |
| 10.1.4.Tonometers |
| 10.1.5.Visual Field Testing Equipment |
| 10.1.6.Others |
| 10.2. Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Closed-angle glaucoma |
| 10.2.2.Open-angle glaucoma |
| 10.2.3.Pigmentary glaucoma |
| 10.2.4.Low tension glaucoma |
| 10.2.5.Others |
| 10.3. End Users Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Ophthalmology Diagnostic Centers |
| 10.3.3.Research Institutes |
| 10.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11. Asia Pacific (APAC) Glaucoma Diagnostic Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Corneal Pachymeters |
| 11.1.2.Optical Coherence Tomography (OCT) Imaging Systems |
| 11.1.3.Retinal Tomography and Angiography Systems |
| 11.1.4.Tonometers |
| 11.1.5.Visual Field Testing Equipment |
| 11.1.6.Others |
| 11.2. Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Closed-angle glaucoma |
| 11.2.2.Open-angle glaucoma |
| 11.2.3.Pigmentary glaucoma |
| 11.2.4.Low tension glaucoma |
| 11.2.5.Others |
| 11.3. End Users Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Ophthalmology Diagnostic Centers |
| 11.3.3.Research Institutes |
| 11.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12. Middle East and Africa (MEA) Glaucoma Diagnostic Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Corneal Pachymeters |
| 12.1.2.Optical Coherence Tomography (OCT) Imaging Systems |
| 12.1.3.Retinal Tomography and Angiography Systems |
| 12.1.4.Tonometers |
| 12.1.5.Visual Field Testing Equipment |
| 12.1.6.Others |
| 12.2. Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Closed-angle glaucoma |
| 12.2.2.Open-angle glaucoma |
| 12.2.3.Pigmentary glaucoma |
| 12.2.4.Low tension glaucoma |
| 12.2.5.Others |
| 12.3. End Users Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Ophthalmology Diagnostic Centers |
| 12.3.3.Research Institutes |
| 12.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13. Latin America Glaucoma Diagnostic Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Corneal Pachymeters |
| 13.1.2.Optical Coherence Tomography (OCT) Imaging Systems |
| 13.1.3.Retinal Tomography and Angiography Systems |
| 13.1.4.Tonometers |
| 13.1.5.Visual Field Testing Equipment |
| 13.1.6.Others |
| 13.2. Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Closed-angle glaucoma |
| 13.2.2.Open-angle glaucoma |
| 13.2.3.Pigmentary glaucoma |
| 13.2.4.Low tension glaucoma |
| 13.2.5.Others |
| 13.3. End Users Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Ophthalmology Diagnostic Centers |
| 13.3.3.Research Institutes |
| 13.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Carl Zeiss Meditec AG (Germany) |
| 14.2.2.Topcon Corporation (Japan) |
| 14.2.3.Heidelberg Engineering GmbH (Germany) |
| 14.2.4.NIDEK CO., LTD (Japan) |
| 14.2.5.Optovue, Incorporated (U.S.) |
| 14.2.6.Leica Microsystems (Germany) |
| 14.2.7.HAAG-STREIT GROUP (U.S.) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Sample
